ATA230477A - Verfahren zur herstellung von neuen piperazin- -und piperidinderivaten, deren tautomeren und salzen - Google Patents
Verfahren zur herstellung von neuen piperazin- -und piperidinderivaten, deren tautomeren und salzenInfo
- Publication number
- ATA230477A ATA230477A AT772304A AT230477A ATA230477A AT A230477 A ATA230477 A AT A230477A AT 772304 A AT772304 A AT 772304A AT 230477 A AT230477 A AT 230477A AT A230477 A ATA230477 A AT A230477A
- Authority
- AT
- Austria
- Prior art keywords
- tautomers
- salt
- production
- piperidine derivatives
- new piperazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
- C07C49/813—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
- C07D213/46—Oxygen atoms
- C07D213/50—Ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67291976A | 1976-04-02 | 1976-04-02 | |
US75306276A | 1976-12-21 | 1976-12-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
ATA230477A true ATA230477A (de) | 1979-12-15 |
AT357541B AT357541B (de) | 1980-07-10 |
Family
ID=27100846
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT230477A AT357541B (de) | 1976-04-02 | 1977-04-01 | Verfahren zur herstellung von neuen piperazin- -und piperidinderivaten, deren tautomeren und salzen |
Country Status (31)
Country | Link |
---|---|
JP (1) | JPS52122380A (de) |
AT (1) | AT357541B (de) |
AU (1) | AU515173B2 (de) |
BG (1) | BG36044A3 (de) |
CA (1) | CA1097646A (de) |
CH (1) | CH634317A5 (de) |
CS (1) | CS191337B2 (de) |
CY (1) | CY1210A (de) |
DE (1) | DE2714437A1 (de) |
DK (1) | DK153477C (de) |
EG (1) | EG12722A (de) |
ES (1) | ES456690A1 (de) |
FI (1) | FI66178C (de) |
FR (1) | FR2346350A1 (de) |
GB (1) | GB1579365A (de) |
GR (1) | GR62465B (de) |
HU (1) | HU179491B (de) |
IE (1) | IE44942B1 (de) |
IL (1) | IL51797A (de) |
IT (1) | IT1086841B (de) |
KE (1) | KE3338A (de) |
LU (1) | LU77052A1 (de) |
MY (1) | MY8400208A (de) |
NL (1) | NL190522C (de) |
NO (1) | NO146774C (de) |
NZ (1) | NZ183506A (de) |
PH (1) | PH12951A (de) |
PT (1) | PT66384B (de) |
SE (1) | SE431333B (de) |
SU (1) | SU683621A3 (de) |
YU (1) | YU39992B (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4181802A (en) * | 1978-05-11 | 1980-01-01 | Janssen Pharmaceutica N.V. | 1-(Heterocyclylalkyl)-1,3-dihydro-2-H-benzimidazole-2-ones |
US4254127A (en) * | 1980-04-03 | 1981-03-03 | Janssen Pharmaceutica, N.V. | 1,3-Dihydro-1-[(1-piperidinyl)alkyl]-2H-benzimidazol-2-one derivatives |
JPS57106663A (en) * | 1980-12-23 | 1982-07-02 | Kyorin Pharmaceut Co Ltd | 1,4-disubstituted piperazine derivative and its preparation |
ES514340A0 (es) * | 1982-06-17 | 1983-09-01 | Ferrer Int | "procedimiento de obtencion de nuevos derivados de piperazina". |
DE3442757A1 (de) * | 1984-11-23 | 1986-05-28 | Wella Ag, 6100 Darmstadt | Verwendung von 2-nitroanilinderivaten in haarfaerbemitteln und neue 2-nitroanilinderivate |
JPS625956A (ja) * | 1985-07-02 | 1987-01-12 | Terumo Corp | ビニル誘導体およびこれを含有する5−リポキシゲナ−ゼ作用阻害剤 |
FR2635524B1 (fr) * | 1988-08-19 | 1992-04-24 | Adir | Nouveaux derives de benzopyrrolidinone, leur procede de preparation et les compositions pharmaceutiques les renfermant |
US5169855A (en) * | 1990-03-28 | 1992-12-08 | Du Pont Merck Pharmaceutical Company | Piperidine ether derivatives as psychotropic drugs or plant fungicides |
IT1251144B (it) * | 1991-07-30 | 1995-05-04 | Boehringer Ingelheim Italia | Derivati del benzimidazolone |
JPH07504905A (ja) * | 1992-03-23 | 1995-06-01 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 抗刺激剤として用いるための薬剤 |
DE59308382D1 (de) * | 1992-11-29 | 1998-05-14 | Clariant Gmbh | Neue asymmetrische, halogenierte Benzophenone und Verfahren zu ihrer Herstellung |
US5883094A (en) * | 1995-04-24 | 1999-03-16 | Pfizer Inc. | Benzimidazolone derivatives with central dopaminergic activity |
US5889010A (en) * | 1995-05-18 | 1999-03-30 | Pfizer Inc. | Benzimidazole derivatives having dopaminergic activity |
IT1292409B1 (it) * | 1997-06-24 | 1999-02-08 | Bidachem Spa | Procedimento per la preparazione di oxatomide |
GB0009479D0 (en) * | 2000-04-17 | 2000-06-07 | Cipla Limited | Antihistaminic compounds |
MXPA03002370A (es) * | 2000-09-19 | 2003-10-15 | Boehringer Ingelheim Pharma | Nuevos derivados bencimidazolona n,n'-disustituidos con afinidad en los receptores de serotonina y dopamina. |
WO2002060878A1 (en) * | 2001-01-30 | 2002-08-08 | Sumitomo Pharmaceuticals Co., Ltd. | Benzimidazolidinone derivatives |
WO2004096794A1 (en) * | 2003-05-01 | 2004-11-11 | Vernalis Research Limited | Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disordrs |
MY150958A (en) * | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
WO2007137417A1 (en) * | 2006-05-26 | 2007-12-06 | Neuromed Pharmaceuticals Ltd. | Heterocyclic compounds as calcium channel blockers |
WO2010128516A2 (en) * | 2009-05-04 | 2010-11-11 | Symed Labs Limited | Process for the preparation of flibanserin involving novel intermediates |
CN104926734B (zh) * | 2015-07-07 | 2017-04-05 | 苏州立新制药有限公司 | 氟班色林的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2882271A (en) * | 1959-04-14 | Xcixcxh | ||
US3362956A (en) * | 1965-08-19 | 1968-01-09 | Sterling Drug Inc | 1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines |
US3369022A (en) * | 1966-11-07 | 1968-02-13 | Robins Co Inc A H | 3-piperazinoalkyl-2-benzoxazolinones |
JPS5070389A (de) * | 1973-10-30 | 1975-06-11 |
-
1977
- 1977-03-02 YU YU566/77A patent/YU39992B/xx unknown
- 1977-03-04 NZ NZ183506A patent/NZ183506A/xx unknown
- 1977-03-09 ES ES456690A patent/ES456690A1/es not_active Expired
- 1977-03-10 FR FR7707106A patent/FR2346350A1/fr active Granted
- 1977-03-14 GR GR52987A patent/GR62465B/el unknown
- 1977-03-14 BG BG7735664A patent/BG36044A3/xx unknown
- 1977-03-18 CA CA274,240A patent/CA1097646A/en not_active Expired
- 1977-03-24 CS CS771972A patent/CS191337B2/cs unknown
- 1977-03-25 CY CY1210A patent/CY1210A/xx unknown
- 1977-03-25 GB GB12754/77A patent/GB1579365A/en not_active Expired
- 1977-03-30 EG EG180/77A patent/EG12722A/xx active
- 1977-03-31 IL IL51797A patent/IL51797A/xx unknown
- 1977-03-31 JP JP3556077A patent/JPS52122380A/ja active Granted
- 1977-03-31 AU AU23824/77A patent/AU515173B2/en not_active Expired
- 1977-03-31 IT IT48768/77A patent/IT1086841B/it active
- 1977-03-31 DE DE19772714437 patent/DE2714437A1/de active Granted
- 1977-03-31 LU LU77052A patent/LU77052A1/xx unknown
- 1977-04-01 DK DK145977A patent/DK153477C/da not_active IP Right Cessation
- 1977-04-01 NO NO771168A patent/NO146774C/no unknown
- 1977-04-01 FI FI771020A patent/FI66178C/fi not_active IP Right Cessation
- 1977-04-01 CH CH415477A patent/CH634317A5/de not_active IP Right Cessation
- 1977-04-01 SU SU772468056A patent/SU683621A3/ru active
- 1977-04-01 NL NLAANVRAGE7703564,A patent/NL190522C/xx not_active IP Right Cessation
- 1977-04-01 IE IE699/77A patent/IE44942B1/en not_active IP Right Cessation
- 1977-04-01 AT AT230477A patent/AT357541B/de not_active IP Right Cessation
- 1977-04-01 SE SE7703842A patent/SE431333B/xx not_active IP Right Cessation
- 1977-04-01 PH PH19620A patent/PH12951A/en unknown
- 1977-04-01 HU HU77JA782A patent/HU179491B/hu unknown
- 1977-04-01 PT PT66384A patent/PT66384B/pt unknown
-
1983
- 1983-10-24 KE KE3338A patent/KE3338A/xx unknown
-
1984
- 1984-12-30 MY MY208/84A patent/MY8400208A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA230477A (de) | Verfahren zur herstellung von neuen piperazin- -und piperidinderivaten, deren tautomeren und salzen | |
AT363099B (de) | Verfahren zur herstellung von neuen guanidinderivaten und von deren saeureadditionssalzen | |
AT363090B (de) | Verfahren zur herstellung von neuen piperazinderivaten und deren salzen | |
AT361912B (de) | Verfahren zur herstellung von neuen heterocyclischen 1-aryloxy-2-hydroxy-3- alkylenaminopropanen und deren salzen | |
AT353762B (de) | Verfahren zur herstellung von neuen omega- aminocarbonsaeurederivaten und deren salzen | |
ATA182577A (de) | Verfahren zur herstellung von neuen piperidin- derivaten und deren salzen | |
AT340926B (de) | Verfahren zur herstellung von neuen, basisch substituierten 1,4-dihydro-2h-isochinolinderivaten sowie deren salzen | |
ATA28277A (de) | Verfahren zur herstellung von neuen thia- zolidinderivaten, deren tautomeren und isomeren formen und deren saeureadditionssalzen | |
AT360972B (de) | Verfahren zur herstellung von neuen amino- benzoesaeureamiden und deren salzen | |
AT351025B (de) | Verfahren zur herstellung von neuen 1,4-dihydro -pyridinen und deren salzen | |
AT357558B (de) | Verfahren zur herstellung von neuen (1,2- dihydro-2-oxo-nicotinamido)-alkyl-benzol- sulfonylharnstoffen und von deren salzen | |
ATA225277A (de) | Verfahren zur herstellung von neuen benzaze- pinen und deren additionssalzen | |
AT346353B (de) | Verfahren zur herstellung von neuen morpholin- , oxazepin- und oxazocin-derivaten und deren salzen | |
AT359507B (de) | Verfahren zur herstellung von neuen piperazin- derivaten und deren salzen | |
AT336601B (de) | Verfahren zur herstellung von neuen cyclopropylphenylpyrrolidin-derivaten und deren salzen | |
AT356661B (de) | Verfahren zur herstellung von neuen glycidsaeure - bzw. thioglycidsaeurederivaten und deren salzen | |
ATA559778A (de) | Verfahren zur herstellung von neuen 1,2- -benzisothiazolen und deren saeureadditions- salzen | |
ATA773277A (de) | Verfahren zur herstellung von neuen azolyl-9,10 -dihydroanthracen-derivaten und deren salzen | |
ATA794078A (de) | Verfahren zur herstellung von neuen piperidin- derivaten und deren salzen | |
ATA648977A (de) | Verfahren zur herstellung von neuen morpholin- derivaten und deren salzen | |
AT337701B (de) | Verfahren zur herstellung von neuen piperidinderivaten und deren salzen | |
ATA586976A (de) | Verfahren zur herstellung von neuen piperidinderivaten und deren salzen | |
ATA587076A (de) | Verfahren zur herstellung von neuen piperidinderivaten und deren salzen | |
ATA369279A (de) | Verfahren zur herstellung von neuen thia- zolidinderivaten, deren tautomeren und isomeren formen und deren saeureadditionssalzen | |
ATA369179A (de) | Verfahren zur herstellung von neuen thia- zolidinderivaten, deren tautomeren und isomeren formen und deren saeureadditionssalzen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELA | Expired due to lapse of time |